Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytarabine in Recurrent or Refractory Ewing Sarcoma
NCT00470275Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- May 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, open-label trial of cytarabine in Ewing sarcoma and primitive neuroectodermal tumor (PNET), sponsored by Children's Oncology Group. Started May 2007; status: completed.
02
Drugs
cytarabine
03
Conditions
Ewing sarcomaprimitive neuroectodermal tumor (PNET)
Beyond the preview
Go deeper on NCT00470275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470275.